Report overview
The global Scopolamine Butylbromide Capsules market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
12 Pieces/Box Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Scopolamine Butylbromide Capsules include AdvaCare Pharma, Zuche Pharmaceuticals, SHRI HARI ENTERPRISE, Facmed Pharmaceuticals Private Limited, Guangzhou Baiyunshan Pharmaceutical Co.,Ltd, Guangdong Huanan Pharmaceutical Group Co., Ltd, Lodays Pharmaceutical(Hubei) Co.,Ltd, Chengdu First Pharmaceutical Co., Ltd and Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Scopolamine Butylbromide Capsules, the indications are 1. It is used for the preoperative preparation of stomach, duodenum and colon endoscopy, endoscopic retrograde cholangiopancreatography, and the preoperative preparation of gas barium hypotonia or abdominal CT scan of stomach, duodenum and colon. Reduce or inhibit gastrointestinal motility; 2. It is used for gastrointestinal spasm, biliary colic, renal colic or hyperperistalsis of gastrointestinal tract caused by various etiologies.
This report aims to provide a comprehensive presentation of the global market for Scopolamine Butylbromide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine Butylbromide Capsules. This report contains market size and forecasts of Scopolamine Butylbromide Capsules in global, including the following market information:
Global Scopolamine Butylbromide Capsules Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Scopolamine Butylbromide Capsules Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Scopolamine Butylbromide Capsules companies in 2023 (%)
We surveyed the Scopolamine Butylbromide Capsules manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Scopolamine Butylbromide Capsules Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Scopolamine Butylbromide Capsules Market Segment Percentages, by Type, 2023 (%)
12 Pieces/Box
24 Pieces/Box
Global Scopolamine Butylbromide Capsules Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Scopolamine Butylbromide Capsules Market Segment Percentages, by Application, 2023 (%)
Gastrointestinal Spasm and Hypermotility
Biliary Colic
Renal Colic
Others
Global Scopolamine Butylbromide Capsules Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Scopolamine Butylbromide Capsules Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Scopolamine Butylbromide Capsules revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Scopolamine Butylbromide Capsules revenues share in global market, 2023 (%)
Key companies Scopolamine Butylbromide Capsules sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Scopolamine Butylbromide Capsules sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AdvaCare Pharma
Zuche Pharmaceuticals
SHRI HARI ENTERPRISE
Facmed Pharmaceuticals Private Limited
Guangzhou Baiyunshan Pharmaceutical Co.,Ltd
Guangdong Huanan Pharmaceutical Group Co., Ltd
Lodays Pharmaceutical(Hubei) Co.,Ltd
Chengdu First Pharmaceutical Co., Ltd
Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Scopolamine Butylbromide Capsules, market overview.
Chapter 2: Global Scopolamine Butylbromide Capsules market size in revenue and volume.
Chapter 3: Detailed analysis of Scopolamine Butylbromide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Scopolamine Butylbromide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Scopolamine Butylbromide Capsules capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
